Psychiatry & Neurology Doctors in West Long Branch, NJ Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Dr. Joshua Todd Mendelson, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 107 Monmouth Rd, Suite 110, West Long Branch, NJ 07764 Phone: 732-935-1850

Dr. Sumul N. Raval, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Hwy 36, Suite 1a, West Long Branch, NJ 07764 Phone: 732-229-6200    Fax: 732-229-6201

Melpomeni Sachla, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 280 Norwood Ave, West Long Branch, NJ 07764 Phone: 732-222-0031    Fax: 732-222-3003

Gabor Barabas, M.D. Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Not Enrolled in Medicare Practice Location: 24 Muncy Dr, West Long Branch, NJ 07764 Phone: 732-571-1297    Fax: 732-229-3167

Dr. Noah R Gilson, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 107 Monmouth Rd, West Long Branch, NJ 07764 Phone: 732-935-1850    Fax: 732-544-0494

Dr. Richard L Worth, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 100 State Route 36 Ste 2r, West Long Branch, NJ 07764 Phone: 732-935-9600    Fax: 732-935-9601

Dr. Paul Gennaro, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 107 Monmouth Rd, West Long Branch, NJ 07764 Phone: 732-935-1850    Fax: 732-544-0494

News Archive

CLEW Medical introduces new AI predictive-analytics platform to prevent complications in care settings

CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.

JAK oral medication produces lasting relief for patients with myelofibrosis: Researchers

An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers at The University of Texas MD Anderson Cancer Center report in the Sept. 16 New England Journal of Medicine.

New protocol for the study of SARS-CoV-2's medium and long-term outcomes

The clinical symptoms of the severe COVID-19 have been well described. In addition, scientists have defined the post-acute COVID-19 as the development of sequelae or persistence of symptoms several weeks after the onset of COVID-19 symptoms. In some cases, the symptoms persist for around 3-4 weeks, and in other cases of chronic COVID-19, symptoms may persist beyond 12 weeks from the onset of symptoms.

Study finds link between genetic variation and cetuximab rectal cancer therapy

team of researchers led by Keck School of Medicine of the University of Southern California (USC) oncologist Heinz-Josef Lenz, M.D., has identified a genetic marker that may predict which patients with rectal cancer can be cured by certain chemotherapies when combined with surgery.

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.

Read more Medical News

› Verified 4 days ago